Latest
Hot
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
Will you subscribe for ANTENGENE's listing in Hong Kong?
德琪醫藥-B將於11月9日—12日招股，每股發行價15.8-18.08港元，每手500股，入場費9131.1港元，預期將於11月20日上市。
作為一家專注於創新抗腫瘤藥物的亞太地區臨床階段生物製藥公司，你會認購嗎？快來曬出你的認購單吧！
德琪醫藥-B將於11月9日—12日招股，每股發行價15.8-18.08港元，每手500股，入場費9131.1港元，預期將於11月20日上市。
作為一家專注於創新抗腫瘤藥物的亞太地區臨床階段生物製藥公司，你會認購嗎？快來曬出你的認購單吧！
作為一家專注於創新抗腫瘤藥物的亞太地區臨床階段生物製藥公司，你會認購嗎？快來曬出你的認購單吧！
Views
2.2M
Posts
82
Follow
Join topic
Related Stocks
No Data
Professional views
Similar Topics
More
- 2026 IPO bonanza! Over 90% of new stocks rose on their debut!52.5M Views · 14K Posts
- Xuanzhu Biotech opened more than 150% higher on its first day. Would you still consider investing?1.1M Views · 333 Posts
- Is the Gray Market Surge Just the Beginning? GenFleet Therapeutics Soars Over 140% on Debut!1.3M Views · 510 Posts
- Zijin Mining and XPL Soar on Debut! Is It Too Late to Buy In?9.3M Views · 1418 Posts
- Dahon Tech's stock opened 36% higher on its first day. Should we take profits or double down?1.3M Views · 199 Posts